Scarica l'app Stockscreener
6.07
3.80%
-0.24
Dopo l'orario di chiusura:
6.07
Shattuck Labs Inc Borsa (STTK) Ultime notizie
Shattuck Labs, Inc.(NasdaqGS: STTK) added to S&P Biotechnology Select Industry Index - marketscreener.com
Shattuck Labs, Inc.(NasdaqGS: STTK) added to S&P Global BMI Index - marketscreener.com
Shattuck Labs Q2 2026 Earnings: Clinical-Stage Balance Sheet in Focus as EPS Meets Estimates - careplusvn.com
Return on invested capital % of Shattuck Labs, Inc. – TRADEGATE:82S - TradingView
Taxes of Shattuck Labs, Inc. – TRADEGATE:82S - TradingView
Shattuck Labs at Wells Fargo conference: DR3 bet takes center stage - Investing.com Canada
Shattuck Labs at Wells Fargo conference: DR3 bet takes center stage By Investing.com - Investing.com South Africa
SHATTUCK LABS STOCK : BIG PRICE RECOVERY | STTK STOCK Darpa Autonomous Drone Swarms (RwCs7APen5) - Mshale
Shattuck Labs Announces Participation in Upcoming September Investor Conferences - Investing News Network
Shattuck Labs (STTK) Gains 2.81% to $7.06 as Momentum Builds Above Key SupportVolume Profile - dars.gov.et
Shattuck Labs: A Receptor-Side Bet On The TL1A Boom - Seeking Alpha
STTK Q2 2026 Earnings: Fractional EPS Miss Triggers 6.67% Selloff in Clinical-Stage BiotechUpward Estimate Revision - vinanet.vn
Raymond James Initiates Coverage on Shattuck Labs With Strong Buy Rating, $18 Price Target - marketscreener.com
Raymond James initiates Shattuck Labs stock with strong buy rating By Investing.com - Investing.com India
Raymond James initiates Shattuck Labs stock with strong buy rating - Investing.com
Shattuck (STTK) EPS and Revenue: The EPS Result Is Above Expectation at the Close; Share Response: Shares Move 3.86% Up for the Current SessionEarnings Expansion Phase - vinanet.vn
Shattuck (STTK) Momentum: Records a 3.86% Increase to $7.53 in the Latest Reading; Level Watch: the $7.15 to $7.91 Range Remains in Focus in the Latest SessionSweep Order Flow - vinanet.vn
Shattuck Labs expects ~$59.4M proceeds from exercised warrants - scanx.trade
Shattuck Labs, Inc. (STTK) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
Shattuck (STTK) Results Snapshot: EPS Clears the Reported Estimate in Latest Trading; Reported Share Move: Shares Finish 0.81% Higher in the Latest SessionEarnings Preview - vinanet.vn
Weekly Recap: SL-325 Phase 2b Crohn’s trial and Q2 loss, $208.3M cash - TradingView
Shattuck Labs (NASDAQ:STTK) Cut to Hold at Wall Street Zen - MarketBeat
T. Rowe Price Investment Management (STTK) reports 15.3% stake in Shattuck Labs - Stock Titan
Several Insiders Invested In Shattuck Labs Flagging Positive News - webull.com
Wall Street Analysts Believe Shattuck Labs (STTK) Could Rally 85.31%: Here's is How to Trade - Yahoo Finance
A Quick Look at Today's Ratings for Shattuck Labs(STTK.US), With a Forecast Between $11 to $18 - Moomoo
Q3 EPS Estimates for Shattuck Labs Raised by HC Wainwright - MarketBeat
Wedbush Maintains Shattuck Labs(STTK.US) With Buy Rating, Maintains Target Price $11 - Moomoo
H.C. Wainwright Maintains Shattuck Labs(STTK.US) With Buy Rating, Maintains Target Price $14 - Moomoo
Shattuck Labs Inc reports results for the quarter ended June 30Earnings Summary - TradingView
H.C. Wainwright cuts Shattuck Labs stock price target on trial expansion - Investing.com
Needham Maintains Shattuck Labs(STTK.US) With Buy Rating, Maintains Target Price $17 - Moomoo
Shattuck Labs Advances SL-325 Crohn’s Trial Toward a Key Value Milestone - TipRanks
Is Shattuck Labs Inc (STTK) Overvalued Following Q2 Earnings Mis - GuruFocus
Shattuck Labs, Inc. Stock 12‑Month Price Target Cut to $14.86, Implies 108% Upside - TradingView
West Tower Group, LLC's Shattuck Labs Inc(STTK) Holding History - GuruFocus
Shattuck Labs, Inc. Stock 12‑Month Price Target Raised to $15.43, Implies 116% Upside - TradingView
STTK Maintained by HC Wainwright & Co. -- Price Target Lowered t - GuruFocus
HC Wainwright Cuts Shattuck Labs (NASDAQ:STTK) Price Target to $14.00 - MarketBeat
Shattuck Labs Raises Cash Reserves to $208.3 Million, Extending Runway to 2029 - Minichart
Shattuck Labs (NASDAQ:STTK) Releases Earnings Results, Hits Expectations - MarketBeat
Shattuck Labs Releases Q2 2026 10-Q Filing Highlighting Key Risk Factors and Share Count - Kalkine Media
Shattuck Labs Q2 Results: EPS misses estimate, losses widen 50% YoY - scanx.trade
Shattuck Labs posts investor deck spotlighting DR3-blocking antibody SL-325 for inflammatory diseases - Bitget
Form 8K Shattuck Labs Inc For: 11 August By Investing.com - Investing.com South Africa
Why is Shattuck Labs stock slipping today? By Investing.com - Investing.com Canada
STTK Looks 580.0% Overvalued on GF Value™ - GuruFocus
Shattuck Labs Reports $15.2 Million Q2 Loss and 2029 Cash Runway - Quiver Quantitative
Shattuck Labs Q2 FY26 net loss widens to $15.2 million; R&D expenses rise to $11.7 million - Bitget
Shattuck Labs Reports Second Quarter 2026 Financial Results and Recent Business Highlights - The Manila Times
Shattuck Labs Reports Positive Phase 1 Data for SL-325 and Advances DR3 Pipeline with Phase 2b Crohn’s Study Planned for 2026 - Quiver Quantitative
Shattuck Labs 2Q Loss $15.2M >STTK - Moomoo
Shattuck Labs Reports $15.2 Million Q2 Loss and 2029 Cash Runway | STTK Stock News - Quiver Quantitative
Shattuck Labs Inc (STTK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Certain Pre-Funded Warrants of Shattuck Labs, Inc. are subject to a Lock-Up Agreement Ending on 9-AUG-2026. - marketscreener.com
Certain Common Stock of Shattuck Labs, Inc. are subject to a Lock-Up Agreement Ending on 9-AUG-2026. - marketscreener.com
3.06%
2.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):